Skip to content
291291291

Drawing based on the description in the official product monograph. No photo yet.

“4 mg tablets are light pink, round, biconvex uncoated mottled tablets debossed with '291' on one side and break line on other side, available in bottles of 30, 100 and 1000 tablets, unit dose cartons of 30 tablets (3 blisters x 10 tablets), 30 tablets (2 blisters x 15 tablets) and 100 tablets (10 blisters x 10 tablets)”

291 pill

Pill with imprint 291 is pink, round and has been identified as Candesartan Cilexetil 4 mg. It is used for high blood pressure, heart failure and a weak heart. It is supplied by Nora Pharma Inc.

Sold in Canada

Candesartan Cilexetil 4 mg

Brand
Nra-Candesartan
Imprint
291
Strength
4 mg
Used for
High blood pressure, heart failure and a weak heart
Color
Pink
Shape
Round
Score
Breaks into 2 pieces
Form
Tablet
Manufacturer
Nora Pharma Inc
Drug class
ARB (blood pressure medicine)
Sold in
Canada
DIN
02527006

Source: Health Canada's Drug Product Database and the official product monograph. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Candesartan Cilexetil pills and guides

What is Candesartan Cilexetil used for?

Candesartan Cilexetil is used for high blood pressure, heart failure, a weak heart and kidney disease from diabetes.

Medicine type
ARB (blood pressure medicine)
Official uses from the US prescribing label

Hypertension

Candesartan cilexetil tablets are indicated for the treatment of hypertension in adults and in children 1 to <17 years of age, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs.

Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program's Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).

Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.

Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.

Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.

Candesartan cilexetil tablets may be used alone or in combination with other antihypertensive agents.

Heart Failure

Candesartan cilexetil tablets are indicated for the treatment of heart failure (NYHA class II-IV) in adults with left ventricular systolic dysfunction (ejection fraction ≤ 40%) to reduce cardiovascular death and to reduce heart failure hospitalizations. Candesartan cilexetil tablets also have an added effect on these outcomes when used with an ACE inhibitor.

From the FDA-approved label on DailyMed (published Sep 09, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows 291.
  • It is pink, round.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold in Canada as Nra-Candesartan by Nora Pharma Inc.

In Canada: prescription only.

Ingredients

Active: Candesartan Cilexetil

Other pills with imprint 291

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Candesartan Cilexetil pills